logo

For the Inventor, By the Inventor

Huddinge, Sweden

Tripep Ab


USPTO Granted Patents = 35

% Expired Patents = 80.0


Forward Citations = 237

Loading Chart...
Loading Chart...

19 inventors (with patents filed for the assignee):

goldMedal Matti Sällberg (24 out of 39 patents)

silverMedal Anders Vahlne (10 out of 12 patents)

bronzeMedal Catharina Hultgren (6 out of 6 patents)

4.  Matti Sällberg (5 out of 5 patents)

5.  Maria Perdomo (4 out of 6 patents)

6.  Laura Goobar-Larsson (4 out of 4 patents)

7.  Sarah Sandin-Reneby (3 out of 3 patents)

8.  Jin Su (3 out of 3 patents)

9.  Stefan Höglund (3 out of 3 patents)

10.  Ákos Végvári (3 out of 3 patents)

11.  Csaba Hetényi (3 out of 3 patents)

12.  David Van Der Spoel (3 out of 3 patents)

13.  Lars Frelin (2 out of 8 patents)

14.  Robert Kamen (1 out of 3 patents)

15.  Jan-Ingmar Flock (1 out of 9 patents)


Core Competencies:
Hepatitis C
Vaccines
Antibody Specificity
Glycosylated Exchangers
Antiviral Composition
Transgenic Models
Peptide Amides
T Cell Receptors
Immunodominant Epitopes
Viral Infectivity
Bacterial Adhesion
Codon Optimization

35 patents:

1. 9457183 - Injection needle and device (2016-10-04),
2. 9284548 - High affinity adaptor molecules for redirecting antibody specifity (2016-03-15),
3. 9193778 - T cell receptors specific for immunodominant CTL epitopes of HCV (2015-11-24),
4. 9079962 - Glycosylated specificity exchangers (2015-07-14),
5. 7638499 - Hepatitis C virus codon optimized non-structural NS3/4A fusion gene (2009-12-29),
6. 7566812 - Transgenic mouse models of hepatitis C virus (HCV) and identification of HCV therapeutics (2009-07-28),
7. 7534435 - Glycosylated specificity exchangers (2009-05-19),
8. 7439347 - Hepatitis C virus non-structural NS3/4A fusion gene (2008-10-21),
9. 7335359 - Glycosylated specificity exchangers (2008-02-26),
10. 7332166 - Glycosylated specificity exchangers (2008-02-19),
11. 7318926 - Glycosylated specificity exchangers (2008-01-15),
12. 7307066 - Hepatitis C virus codon optimized non-structural NS3/4A fusion gene (2007-12-11),
13. 7261883 - Vaccines containing ribavirin and methods of use thereof (2007-08-28),
14. 7244715 - Vaccines containing ribavirin and methods of use thereof (2007-07-17),
15. 7244422 - Vaccines containing ribavirin and methods of use thereof (2007-07-17),
Company Overview
Tripep Ab is a biotechnology company based in Huddinge, Sweden, specializing in the development of innovative therapeutic solutions. The organization focuses on advancing treatments in the fields of immunology and infectious diseases, leveraging cutting-edge research to create effective and safe medical products. Tripep's commitment to scientific excellence and collaboration positions it as a key player in the biopharmaceutical landscape, aiming to address unmet medical needs through its pioneering technologies and research initiatives.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

35 Patents

#2 in Huddinge

#196 in Sweden

#19,148 in the World

Huddinge, SE
Huddinge, Sweden

Tripep Ab

Forward Citations = 237

19 inventors:

goldMedal Matti Sällberg (24 out of 39 patents)

silverMedal Anders Vahlne (10 out of 12 patents)

bronzeMedal Catharina Hultgren (6 out of 6 patents)

4.  Matti Sällberg (5 out of 5 patents)

5.  Maria Perdomo (4 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Tripep Ab. Retrieved from https://idiyas.com/company/tripep-ab

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…